A Serosurvey Identifying Vulnerability to Measles in Health Care Workers. A Hospital-Based Prospective Seroprevalence Study.
health care workers
measles antibodies
persistence
seroprevalence
serosurvey
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
12 06 2020
12 06 2020
Historique:
received:
06
05
2020
revised:
06
06
2020
accepted:
10
06
2020
entrez:
18
6
2020
pubmed:
18
6
2020
medline:
27
10
2020
Statut:
epublish
Résumé
The aim of this serological survey was to assess the persistence of measles antibodies among health care workers (HCWs) at risk of incidental measles. A prospective study of measles-specific antibodies in serum samples obtained from a total of 2782 participants aged 19-89 years was conducted between May 2018 and December 2019. The seropositivity rate of 93.7% (95% CI: 92.4-94.9%) in fully vaccinated participants aged 19-48 years was significantly lower than that of 98.0% (95% CI: 96.5-99.0%) in participants naturally immunised before 54 years. A cohort of those born in 1971-1975, vaccinated predominantly with one dose, showed lower seropositivity persistence (86.6%) than those fully vaccinated with two doses or naturally immunised. Otherwise, seropositivity was not markedly influenced by sex, age, smoking status, overweight, obesity or concomitant disease. The presence of sufficient antibody levels in a high proportion of HCWs irrespective of the way they acquired immunity is a favourable finding for managing incidental measles; hence, in the presence of a risk of a measles outbreak, it would be possible to perform targeted vaccination of only at-risk HCWs with a history of incomplete vaccination or missing information about the way in which immunity is acquired.
Identifiants
pubmed: 32545706
pii: ijerph17124219
doi: 10.3390/ijerph17124219
pmc: PMC7345454
pii:
doi:
Substances chimiques
Antibodies, Viral
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Cent Eur J Public Health. 2018 Mar;26(1):22-27
pubmed: 29684293
Vaccine. 2003 Nov 7;21(31):4597-603
pubmed: 14575773
Int J Epidemiol. 2009 Feb;38(1):192-205
pubmed: 19188207
Vaccine. 2008 Aug 12;26(34):4403-9
pubmed: 18585420
Eur J Public Health. 2012 Feb;22(1):133-9
pubmed: 20880991
J Occup Health. 2009;51(1):97-9
pubmed: 19096198
Epidemiol Infect. 2014 Jan;142(1):12-9
pubmed: 23574767
Clin Infect Dis. 2006 Feb 1;42(3):322-8
pubmed: 16392075
Vaccine. 2014 Aug 27;32(38):4814-22
pubmed: 24726251
BMC Infect Dis. 2013 Aug 26;13:391
pubmed: 23978316
Hum Vaccin Immunother. 2013 Sep;9(9):1918-25
pubmed: 23793571
Euro Surveill. 2011 Jan 13;16(2):
pubmed: 21251488
Rev Infect Dis. 1983 May-Jun;5(3):477-81
pubmed: 6879002
Wkly Epidemiol Rec. 2009 Aug 28;84(35):349-60
pubmed: 19714924
Biologicals. 1994 Mar;22(1):35-44
pubmed: 8068312
Nat Commun. 2018 Nov 23;9(1):4944
pubmed: 30470742
Epidemiol Infect. 2014 May;142(5):1100-8
pubmed: 23915981
Vaccine. 2015 Sep 22;33(39):5057-63
pubmed: 26319061
Occup Med (Lond). 2019 Apr 13;69(2):143-145
pubmed: 30295885
Vaccines (Basel). 2020 Feb 03;8(1):
pubmed: 32028593